ITMI20020510A0 - COMPOSITIONS FOR TOPICAL USE CONTAINING L-CYSTEINE DERIVATIVES - Google Patents

COMPOSITIONS FOR TOPICAL USE CONTAINING L-CYSTEINE DERIVATIVES

Info

Publication number
ITMI20020510A0
ITMI20020510A0 IT2002MI000510A ITMI20020510A ITMI20020510A0 IT MI20020510 A0 ITMI20020510 A0 IT MI20020510A0 IT 2002MI000510 A IT2002MI000510 A IT 2002MI000510A IT MI20020510 A ITMI20020510 A IT MI20020510A IT MI20020510 A0 ITMI20020510 A0 IT MI20020510A0
Authority
IT
Italy
Prior art keywords
compositions
topical use
use containing
cysteine derivatives
cysteine
Prior art date
Application number
IT2002MI000510A
Other languages
Italian (it)
Original Assignee
Ghisalberti Carlo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ghisalberti Carlo filed Critical Ghisalberti Carlo
Priority to IT2002MI000510A priority Critical patent/ITMI20020510A1/en
Publication of ITMI20020510A0 publication Critical patent/ITMI20020510A0/en
Priority to AU2003209542A priority patent/AU2003209542A1/en
Priority to PCT/IB2003/000857 priority patent/WO2003075901A2/en
Publication of ITMI20020510A1 publication Critical patent/ITMI20020510A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/08—Antiseborrheics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IT2002MI000510A 2002-03-11 2002-03-11 TOPICAL COMPOSITIONS CONTAINING L-CISTEIN DERIVATIVES ITMI20020510A1 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
IT2002MI000510A ITMI20020510A1 (en) 2002-03-11 2002-03-11 TOPICAL COMPOSITIONS CONTAINING L-CISTEIN DERIVATIVES
AU2003209542A AU2003209542A1 (en) 2002-03-11 2003-03-10 Use of s-substituted l-crysteine for the manufacture of a medicament for the treatment of dermatological disorders
PCT/IB2003/000857 WO2003075901A2 (en) 2002-03-11 2003-03-10 Use of s-substituted l-crysteine for the manufacture of a medicament for the treatment of dermatological disorders

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT2002MI000510A ITMI20020510A1 (en) 2002-03-11 2002-03-11 TOPICAL COMPOSITIONS CONTAINING L-CISTEIN DERIVATIVES

Publications (2)

Publication Number Publication Date
ITMI20020510A0 true ITMI20020510A0 (en) 2002-03-11
ITMI20020510A1 ITMI20020510A1 (en) 2003-09-11

Family

ID=11449487

Family Applications (1)

Application Number Title Priority Date Filing Date
IT2002MI000510A ITMI20020510A1 (en) 2002-03-11 2002-03-11 TOPICAL COMPOSITIONS CONTAINING L-CISTEIN DERIVATIVES

Country Status (3)

Country Link
AU (1) AU2003209542A1 (en)
IT (1) ITMI20020510A1 (en)
WO (1) WO2003075901A2 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7351745B2 (en) * 2004-12-22 2008-04-01 Avon Products, Inc Compositions and methods of their use for improving the condition and appearance of skin
CN101467991B (en) * 2007-08-02 2012-02-01 复旦大学 Uses of allyl cysteine and analogue thereof in preparing medicament for treating myocardial damage
JP6596733B2 (en) * 2015-07-14 2019-10-30 学校法人日本大学 COMPOUND, PROTEIN MODIFICATION REAGENT CONTAINING THE COMPOUND, AND METHOD FOR LABELING PROTEIN
US20180362456A1 (en) * 2015-12-07 2018-12-20 Ems S/A New compounds with antioxidant and antiaging activity
JP7356707B2 (en) * 2018-11-15 2023-10-05 国立大学法人神戸大学 Method for producing amino acid-N-carboxylic acid anhydride
CN115501125A (en) * 2022-10-20 2022-12-23 澳门科技大学 H for repairing skin lesions 2 S donor gel and H 2 Preparation method of S donor gel

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE733993A (en) * 1968-06-14 1969-12-03
US3671643A (en) * 1969-09-15 1972-06-20 Oreal Treatment of excessive sebaceous glands secretion with substituted cysteamine compounds
BE788945A (en) * 1971-09-20 1973-03-19 Oreal
FR2155776B1 (en) * 1971-10-04 1974-11-15 Rech Pharmaceut Scient
FR2187326B1 (en) * 1972-06-15 1975-10-17 Rech Pharm Scientifiques
US4827016A (en) * 1985-09-16 1989-05-02 Morgan Lee R Method and compounds for reducing dermal inflammations

Also Published As

Publication number Publication date
WO2003075901A3 (en) 2003-12-31
ITMI20020510A1 (en) 2003-09-11
AU2003209542A8 (en) 2003-09-22
WO2003075901A2 (en) 2003-09-18
AU2003209542A1 (en) 2003-09-22

Similar Documents

Publication Publication Date Title
FR2842417B1 (en) COSMETIC COMPOSITION
FR2842416B1 (en) COSMETIC COMPOSITION
DK3536344T3 (en) SUPERFIN FORMOTHER FORMULATION
DE60311307D1 (en) SHAMPOO COMPOSITIONS
FR2862654B1 (en) FILMOGENATED AMYLACEE COMPOSITION
DE10393374D2 (en) composition
SE0500163L (en) Composition
ATE352301T1 (en) ANTINEOPLASTIC COMPOSITIONS
DE60310914D1 (en) POWDER COMPOSITION
DK1587478T3 (en) PHARMACEUTICAL COMPOSITION
DE602004018512D1 (en) PENS COMPOSITIONS
DK1561472T3 (en) Solid Composition
DE60316954D1 (en) SHAMPOO COMPOSITIONS
ITMI20020510A0 (en) COMPOSITIONS FOR TOPICAL USE CONTAINING L-CYSTEINE DERIVATIVES
DE60304501D1 (en) Rustproofing composition
DE60326900D1 (en) Perfume composition
DE60300602D1 (en) Thiazole derivatives containing curable composition
DE60319277D1 (en) COATING COMPOSITION
NO20024880D0 (en) Composition containing phosphate
NO20044140D0 (en) New Composition
EE200300465A (en) Pharmaceutical compositions based on pyridoindolone derivatives
DE602004007221D1 (en) Antiperspirant compositions
ITMI20020508A0 (en) COMPOSITIONS FOR TOPICAL USE CONTAINING FURANIC DERIVATIVES
ITMI20020872A0 (en) HYPERFORIN DERIVATIVES, THEIR USE AND FORMULATIONS THAT CONTAIN THEM
NO20044164L (en) Pharmaceutical compositions